Torrent Pharmaceuticals

TORNTPHARM

₹ 3,401.52

₹ 4.12

0.12%

Modeled data

Torrent Pharmaceuticals
Market Sentiment

Timeline	Returns	Volume
Daily	0.12	1,87,075
Weekly	1.50%	7,99,239
Monthly	2.87%	37,61,808

Torrent Pharmaceuticals
Performance

Timeline	Daily	Weekly	Monthly
TORNTPHARM	0.12	1.50%	2.87%
Index	-	-	-
Peer Avg.	-0.00%	2.70%	13.69%

*Avg of index constituents

Torrent Pharmaceuticals
Fundamentals

Timeline	PE	PB	EV/EBIDTA	ROE	ROCE	Div. Yield
TORNTPHARM	27.16	7.70	21.28	14.60	15.65	3.09
Index	35.44	5.98	16.81	16.99	18.41	1.19
Peer Avg.	38.60	4.35	13.48	12.96	16.49	0.78

*Avg of index constituents

Torrent Pharmaceuticals
Key Metrics

Metrics	Sales Growth	Profit Growth	ROE	ROCE
FY '21-22	5.41%	-25.39%	14.60%	15.65%
FY '20-21	2.70%	21.70%	21.95%	16.96%
FY '19-20	5.26%	80.38%	19.99%	14.98%

Torrent Pharmaceuticals
Shareholding Pattern

Promoters : 71.25%

FII : 10.88%

DII : 9.74%

Public : 8.14%

Others : 0%

Torrent Pharmaceuticals
Profit & Loss

Metrics	Sales	Expenditure	EBITDA	PAT
FY '21-22	7,625.18	5,359.17	2,466.38	884.32
FY '20-21	7,227.57	4,891.66	2,423.53	1,194.87
FY '19-20	7,053.88	5,010.20	2,222.79	981.62

All values are in crores

Torrent Pharmaceuticals
Peer Comparison

Metrics	Sales	Expenditure	EBITDA	PAT
TORNTPHARM	7,625.18	5,359.17	2,466.38	884.32
ZYDUSLIFE	11,623.55	9,000.35	2,831.10	1,592.15
MANKIND	8,749.43	6,847.50	2,030.50	1,309.68

All values are in crores

Torrent Pharmaceuticals Share Price

Torrent Pharmaceuticals Limited is an Indian pharmaceutical company. The company's field of activity is the research, development, production and marketing of generic medicines. It operates in the therapeutic segments Cardiovascular (CV), Gastrointestinal (GI), Central and Central Nervous System, and Vitamin, Mineral Nutrients (VMN). It is also used in therapeutic areas such as anti-epileptic drugs, diabetes treatment, anti-cancer drugs, anti-acne drugs, corticosteroids and cosmetics. It is complex dosage forms developed for the global market based on oral solids, injections, inhalation technologies, long-term depot injections for ophthalmic, nasal, semi-solids for external use and multiparticulate sustained-release oral systems. The company develops various in-house new chemical entities (NCE) in the areas of metabolic, cardiovascular, gastrointestinal, dermatology and respiratory diseases. It is represented in more than 40 countries.

Torrent Pharmaceuticals FAQs

How to Buy Torrent Pharmaceuticals Share?

To purchase Torrent Pharmaceuticals shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Torrent Pharmaceuticals (ticker symbol: TORNTPHARM) on the trading platform provided by your broker and purchase the shares.

What's Torrent Pharmaceuticals share price today?

The stock price of Torrent Pharmaceuticals as of 13 Sep 2024 is ₹3,401.52

What is the Market Cap of Torrent Pharmaceuticals?

Market capitalisation represents the total market value of a company's outstanding shares. As of 13 Sep 2024, Torrent Pharmaceuticals (ticker symbol: TORNTPHARM) has a market capitalisation of approximately ₹5,25,13,19,44,704.00

What is the PE and PB ratio of Torrent Pharmaceuticals?

Torrent Pharmaceuticals Ltd's price-to-book ratio as of 13 Sep 2024 is 7.7039194, reflecting the market's valuation compared to its asset value. As of 13 Sep 2024, the trailing twelve months P/E (price-to-earnings) ratio is 27.156334, indicating the market values the company at around ₹27.16 for every ₹1 of earnings